Delivering our partners preclinical discoveries through world class capabilities,
directed by teams with a reputation for collaboration and scientific excellence
Feb 2019 OncoWuXi Newsletter
Feb issue OncoWuXi Newsletter will share with you the update on immune checkpoint humanized knockin mouse tumor models and immune avatar humanized mouse models.
GIP and GLP-1 Receptor Assay Platforms.
Dual GIP and GLP-1 receptor agonist is more effective than solo GLP-1 receptor agonist in the reduction of blood sugar and body weight in patients with type 2 diabetes
Tim Shannon, Canaan
Early Stage: An Inside Look at How Personal Experience Translates into Next-Generation Biotechs & Treatments for Patients.
Human Cancer Cell Bank
November 2018 Biology Newsletter
Human cancer cell lines provide a strong tool for early stage screening and development of anti-tumor candidates.
To Empower Organic Syntheses
With powerful workstations, state of the art software, and our expertise on reaction QM analyses, real-time incorporations of such calculations in prospective analyses become routines in Research Service Division.
DNA Encoded Library
Accelerator for DEL Technology
Instant Access to Billion of Compounds at Affordable Price. WuXi’s end-to-end platform enables smooth transition from DEL hit to hit validation, leading to downstream medicinal chemistry activities.